ENvue Medical Free Cash Flow (FCF) History (FEED)
ENvue Medical reported −$9.4M in free cash flow for fiscal 2025, a decrease of $6.9M from the previous fiscal year, with a free cash flow margin of −369.45%.
View full ENvue Medical company overviewENvue Medical free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$9.4M | −$6.9M | — | −369.45% |
| 2024 | 2024-12-31 | −$2.5M | $1.1M | — | −98.48% |
| 2023 | 2023-12-31 | −$3.6M | $3.4M | — | −157.82% |
| 2022 | 2022-12-31 | −$7.0M | −$2.7M | — | −935.90% |
| 2021 | 2021-12-31 | −$4.4M | −$977,000 | — | −257.82% |
| 2020 | 2020-12-31 | −$3.4M | $165,000 | — | −544.62% |
| 2018 | 2018-12-31 | −$3.6M | −$2.0M | — | −1118.87% |
| 2016 | 2016-12-31 | −$1.5M | −$60,000 | — | −672.93% |
| 2015 | 2015-12-31 | −$1.5M | −$577,000 | — | −1007.48% |
| 2014 | 2014-12-31 | −$904,000 | — | — | −445.32% |
ENvue Medical quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.7M | $669,000 | — | −1137.24% |
| Q1 2026 | 2026-03-31 | −$4.3M | −$3.0M | — | −662.94% |
| Q4 2025 | 2025-12-31 | −$2.7M | −$2.2M | — | −865.06% |
| Q3 2025 | 2025-09-30 | −$2.0M | −$1.2M | — | −276.73% |
| Q2 2025 | 2025-06-30 | −$3.4M | −$2.8M | — | −685.63% |
| Q1 2025 | 2025-03-31 | −$1.3M | −$768,000 | — | −131.51% |
| Q4 2024 | 2024-12-31 | −$548,000 | −$57,000 | — | −123.42% |
| Q3 2024 | 2024-09-30 | −$836,000 | −$154,000 | — | −222.34% |
| Q2 2024 | 2024-06-30 | −$555,000 | $674,000 | — | −67.93% |
| Q1 2024 | 2024-03-31 | −$580,000 | $621,000 | — | −62.98% |
| Q4 2023 | 2023-12-31 | −$491,000 | $1.5M | — | −41.72% |
| Q3 2023 | 2023-09-30 | −$682,000 | $181,000 | — | −148.91% |
| Q2 2023 | 2023-06-30 | −$1.2M | −$594,000 | — | −418.03% |
| Q1 2023 | 2023-03-31 | −$1.2M | $715,000 | — | −339.27% |
| Q3 2022 | 2022-09-30 | −$2.0M | −$1.0M | — | −2026.80% |
| Q4 2021 | 2021-12-31 | −$863,000 | $18,000 | — | −111.35% |
| Q3 2021 | 2021-09-30 | −$635,000 | $165,000 | — | −127.25% |
| Q2 2021 | 2021-06-30 | −$1.9M | −$908,000 | — | −602.52% |
| Q1 2021 | 2021-03-31 | −$956,000 | −$87,000 | — | −928.16% |
| Q4 2018 | 2018-12-31 | −$881,000 | −$398,000 | — | −1601.82% |
| Q3 2018 | 2018-09-30 | −$800,000 | −$284,000 | — | −1481.48% |
| Q2 2018 | 2018-06-30 | −$1.0M | −$603,000 | — | −763.64% |
| Q1 2018 | 2018-03-31 | −$869,000 | −$443,000 | — | −1128.57% |
| Q3 2017 | 2017-09-30 | −$483,000 | −$216,000 | — | −743.08% |
| Q2 2017 | 2017-06-30 | −$516,000 | −$37,000 | — | −992.31% |
| Q1 2017 | 2017-03-31 | −$405,000 | −$36,000 | — | −778.85% |
| Q4 2016 | 2016-12-31 | −$426,000 | −$46,000 | — | −869.39% |
| Q3 2016 | 2016-09-30 | −$267,000 | −$3,000 | — | −437.70% |
| Q2 2016 | 2016-06-30 | −$479,000 | $59,000 | — | −772.58% |
| Q1 2016 | 2016-03-31 | −$369,000 | −$70,000 | — | −647.37% |
| Q4 2015 | 2015-12-31 | −$380,000 | −$112,000 | — | −974.36% |
| Q3 2015 | 2015-09-30 | −$264,000 | — | — | −660.00% |
| Q2 2015 | 2015-06-30 | −$538,000 | — | — | −1379.49% |
| Q1 2015 | 2015-03-31 | −$299,000 | — | — | −1031.03% |
| Q3 2014 | 2014-09-30 | −$268,000 | — | — | −1072.00% |
ENvue Medical free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$3.4M to −$9.4M, a net decrease of $6.0M. ENvue Medical's latest reported quarter, Q2 2026, generated −$2.7M in free cash flow, an increase of $669,000 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review ENvue Medical filings at SEC.gov ↗